• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心脏病中的内皮细胞功能障碍:是驱动因素还是结果?

Endothelial cell dysfunction in cardiac disease: driver or consequence?

作者信息

Allbritton-King Jules D, García-Cardeña Guillermo

机构信息

Department of Pathology, Center for Excellence in Vascular Biology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, United States.

Cardiovascular Disease Initiative, Broad Institute of MIT and Harvard, Cambridge, MA, United States.

出版信息

Front Cell Dev Biol. 2023 Oct 25;11:1278166. doi: 10.3389/fcell.2023.1278166. eCollection 2023.

DOI:10.3389/fcell.2023.1278166
PMID:37965580
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10642230/
Abstract

The vascular endothelium is a multifunctional cellular system which directly influences blood components and cells within the vessel wall in a given tissue. Importantly, this cellular interface undergoes critical phenotypic changes in response to various biochemical and hemodynamic stimuli, driving several developmental and pathophysiological processes. Multiple studies have indicated a central role of the endothelium in the initiation, progression, and clinical outcomes of cardiac disease. In this review we synthesize the current understanding of endothelial function and dysfunction as mediators of the cardiomyocyte phenotype in the setting of distinct cardiac pathologies; outline existing and models where key features of endothelial cell dysfunction can be recapitulated; and discuss future directions for development of endothelium-targeted therapeutics for cardiac diseases with limited existing treatment options.

摘要

血管内皮是一个多功能细胞系统,它直接影响给定组织内的血液成分和血管壁内的细胞。重要的是,这种细胞界面会对各种生化和血流动力学刺激作出关键的表型变化,驱动多种发育和病理生理过程。多项研究表明内皮在心脏病的发生、发展和临床结局中起核心作用。在本综述中,我们综合了目前对内皮功能和功能障碍的理解,它们作为不同心脏病理情况下心肌细胞表型的介质;概述了可以重现内皮细胞功能障碍关键特征的现有模型;并讨论了针对现有治疗选择有限的心脏病开发内皮靶向治疗的未来方向。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/69fb/10642230/f5971d8cdac2/fcell-11-1278166-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/69fb/10642230/7fb45735a9f6/fcell-11-1278166-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/69fb/10642230/a326a7343ded/fcell-11-1278166-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/69fb/10642230/b1e185272d24/fcell-11-1278166-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/69fb/10642230/f5971d8cdac2/fcell-11-1278166-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/69fb/10642230/7fb45735a9f6/fcell-11-1278166-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/69fb/10642230/a326a7343ded/fcell-11-1278166-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/69fb/10642230/b1e185272d24/fcell-11-1278166-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/69fb/10642230/f5971d8cdac2/fcell-11-1278166-g004.jpg

相似文献

1
Endothelial cell dysfunction in cardiac disease: driver or consequence?心脏病中的内皮细胞功能障碍:是驱动因素还是结果?
Front Cell Dev Biol. 2023 Oct 25;11:1278166. doi: 10.3389/fcell.2023.1278166. eCollection 2023.
2
Cardiac endothelial-myocardial signaling: its role in cardiac growth, contractile performance, and rhythmicity.心脏内皮-心肌信号传导:其在心脏生长、收缩功能和节律性中的作用。
Physiol Rev. 2003 Jan;83(1):59-115. doi: 10.1152/physrev.00017.2002.
3
Endothelial cell-cardiomyocyte crosstalk in heart development and disease.内皮细胞-心肌细胞的串扰在心脏发育和疾病中的作用。
J Physiol. 2020 Jul;598(14):2923-2939. doi: 10.1113/JP276758. Epub 2019 Mar 27.
4
Endothelial dysfunction - a major mediator of diabetic vascular disease.内皮功能障碍——糖尿病血管疾病的主要介导因素。
Biochim Biophys Acta. 2013 Dec;1832(12):2216-31. doi: 10.1016/j.bbadis.2013.08.006. Epub 2013 Aug 29.
5
Endothelial Dysfunction in Atherosclerotic Cardiovascular Diseases and Beyond: From Mechanism to Pharmacotherapies.动脉粥样硬化性心血管疾病及其以外的血管内皮功能障碍:从机制到药物治疗。
Pharmacol Rev. 2021 Jul;73(3):924-967. doi: 10.1124/pharmrev.120.000096.
6
Cooperation of liver cells in health and disease.健康与疾病状态下肝细胞的协作。
Adv Anat Embryol Cell Biol. 2001;161:III-XIII, 1-151. doi: 10.1007/978-3-642-56553-3.
7
Platelet endothelial cell adhesion molecule-1 mediates endothelial-cardiomyocyte communication and regulates cardiac function.血小板内皮细胞黏附分子-1介导内皮细胞与心肌细胞的通讯并调节心脏功能。
J Am Heart Assoc. 2015 Jan 19;4(1):e001210. doi: 10.1161/JAHA.114.001210.
8
The role of angiotensin II, endothelin-1 and transforming growth factor-beta as autocrine/paracrine mediators of stretch-induced cardiomyocyte hypertrophy.血管紧张素II、内皮素-1及转化生长因子-β作为牵张诱导心肌细胞肥大的自分泌/旁分泌介质的作用
Mol Cell Biochem. 2001 Feb;218(1-2):113-24. doi: 10.1023/a:1007279700705.
9
Angiogenic Endothelial Cell Signaling in Cardiac Hypertrophy and Heart Failure.心脏肥大和心力衰竭中的血管生成性内皮细胞信号传导
Front Cardiovasc Med. 2019 Mar 6;6:20. doi: 10.3389/fcvm.2019.00020. eCollection 2019.
10
Cardiac myocyte p38α kinase regulates angiogenesis via myocyte-endothelial cell cross-talk during stress-induced remodeling in the heart.在心脏应激诱导重塑过程中,心肌细胞p38α激酶通过心肌细胞与内皮细胞的相互作用调节血管生成。
J Biol Chem. 2017 Aug 4;292(31):12787-12800. doi: 10.1074/jbc.M117.784553. Epub 2017 Jun 21.

引用本文的文献

1
A Refined Carbohydrate-Rich Diet Reduces Vascular Reactivity Through Endothelial Oxidative Stress and Increased Nitric Oxide: The Involvement of Inducible Nitric Oxide Synthase.富含精制碳水化合物的饮食通过内皮氧化应激和一氧化氮增加降低血管反应性:诱导型一氧化氮合酶的作用。
Nutrients. 2025 Jul 22;17(15):2395. doi: 10.3390/nu17152395.
2
Protective Effect of -Acetylcysteine (NAC) on oxLDL-Induced Endothelial Dysfunction.N-乙酰半胱氨酸(NAC)对氧化型低密度脂蛋白(oxLDL)诱导的内皮功能障碍的保护作用。
J Microbiol Biotechnol. 2025 Aug 5;35:e2504039. doi: 10.4014/jmb.2504.04039.
3
Molecular and Biochemical Mechanisms of Cardiomyopathy Development Following Prenatal Hypoxia-Focus on the NO System.

本文引用的文献

1
Spatial Transcriptomic Analysis of Focal and Normal Areas of Myocyte Disarray in Human Hypertrophic Cardiomyopathy.心肌细胞排列紊乱的局灶区和正常区的空间转录组分析在人类肥厚型心肌病中的应用。
Int J Mol Sci. 2023 Aug 10;24(16):12625. doi: 10.3390/ijms241612625.
2
Semaglutide in Patients with Heart Failure with Preserved Ejection Fraction and Obesity.司美格鲁肽治疗射血分数保留的心力衰竭合并肥胖患者的疗效。
N Engl J Med. 2023 Sep 21;389(12):1069-1084. doi: 10.1056/NEJMoa2306963. Epub 2023 Aug 25.
3
Vascularized hiPSC-derived 3D cardiac microtissue on chip.
产前缺氧后心肌病发展的分子和生化机制——聚焦于一氧化氮系统
Antioxidants (Basel). 2025 Jun 16;14(6):743. doi: 10.3390/antiox14060743.
4
Endothelial dysfunction in cardiovascular diseases: mechanisms and in vitro models.心血管疾病中的内皮功能障碍:机制与体外模型
Mol Cell Biochem. 2025 Apr 21. doi: 10.1007/s11010-025-05289-w.
5
Endothelial Dysfunction: Redox Imbalance, NLRP3 Inflammasome, and Inflammatory Responses in Cardiovascular Diseases.内皮功能障碍:氧化还原失衡、NLRP3炎性小体与心血管疾病中的炎症反应
Antioxidants (Basel). 2025 Feb 23;14(3):256. doi: 10.3390/antiox14030256.
6
Molecular pathways in cardiovascular disease under hypoxia: Mechanisms, biomarkers, and therapeutic targets.缺氧状态下心血管疾病的分子通路:机制、生物标志物及治疗靶点
J Biomed Res. 2025 Mar 20;39(3):254-269. doi: 10.7555/JBR.38.20240387.
7
Overexpression of ABCA1 in Carotid Endothelium of Hyperlipidemic Rabbits Modulates Vascular Inflammation.高脂血症兔颈动脉内皮中ABCA1的过表达调节血管炎症。
Hum Gene Ther. 2025 Apr;36(7-8):750-764. doi: 10.1089/hum.2024.166. Epub 2025 Mar 20.
8
Advancing Cardiac Organoid Engineering Through Application of Biophysical Forces.通过生物物理力的应用推进心脏类器官工程。
IEEE Rev Biomed Eng. 2024 Dec 9;PP. doi: 10.1109/RBME.2024.3514378.
9
The roles of melatonin and potassium channels in relaxation response to ang 1-7 in diabetic rat isolated aorta.褪黑素和钾通道在糖尿病大鼠离体主动脉对血管紧张素1-7舒张反应中的作用
Cytotechnology. 2025 Apr;77(2):55. doi: 10.1007/s10616-025-00720-y. Epub 2025 Feb 5.
10
Endothelial Dysfunction in Acute Myocardial Infarction: A Complex Association With Sleep Health, Traditional Cardiovascular Risk Factors and Prognostic Markers.急性心肌梗死中的内皮功能障碍:与睡眠健康、传统心血管危险因素及预后标志物的复杂关联
Clin Cardiol. 2025 Jan;48(1):e70080. doi: 10.1002/clc.70080.
血管化 hiPSC 来源的 3D 心脏微组织芯片。
Stem Cell Reports. 2023 Jul 11;18(7):1394-1404. doi: 10.1016/j.stemcr.2023.06.001. Epub 2023 Jun 29.
4
Microvascular resistance reserve: diagnostic and prognostic performance in the ILIAS registry.微血管阻力储备:ILIAS 登记研究中的诊断和预后性能。
Eur Heart J. 2023 Aug 7;44(30):2862-2869. doi: 10.1093/eurheartj/ehad378.
5
Coronary Microvascular Disease in Contemporary Clinical Practice.当代临床实践中的冠状动脉微血管疾病。
Circ Cardiovasc Interv. 2023 Jun;16(6):e012568. doi: 10.1161/CIRCINTERVENTIONS.122.012568. Epub 2023 Jun 1.
6
SGLT2 inhibition ameliorates nano plastics-induced premature endothelial senescence and dysfunction.SGLT2 抑制改善纳米塑料诱导的内皮过早衰老和功能障碍。
Sci Rep. 2023 Apr 17;13(1):6256. doi: 10.1038/s41598-023-33086-2.
7
Recent Advances in Generation of In Vitro Cardiac Organoids.体外心脏类器官的最新进展。
Int J Mol Sci. 2023 Mar 26;24(7):6244. doi: 10.3390/ijms24076244.
8
Endothelin-1, Outcomes in Patients With Heart Failure and Reduced Ejection Fraction, and Effects of Dapagliflozin: Findings From DAPA-HF.内皮素-1、射血分数降低的心力衰竭患者的结局,以及达格列净的影响:来自 DAPA-HF 的结果。
Circulation. 2023 May 30;147(22):1670-1683. doi: 10.1161/CIRCULATIONAHA.122.063327. Epub 2023 Apr 11.
9
Endothelial-derived extracellular vesicles from obese/hypertensive adults increase factors associated with hypertrophy and fibrosis in cardiomyocytes.肥胖/高血压成年人来源的内皮细胞外囊泡增加与心肌细胞肥大和纤维化相关的因子。
Am J Physiol Heart Circ Physiol. 2023 May 1;324(5):H675-H685. doi: 10.1152/ajpheart.00035.2023. Epub 2023 Mar 17.
10
Molecular Mechanisms and Therapeutic Implications of Endothelial Dysfunction in Patients with Heart Failure.心力衰竭患者内皮功能障碍的分子机制及治疗意义。
Int J Mol Sci. 2023 Feb 21;24(5):4321. doi: 10.3390/ijms24054321.